PulseAugur
EN
LIVE 13:51:37
中文(ZH) 华大智造:控股股东提议公司以2.5亿元—5亿元回购股份

BGI Genomics proposes share buyback amid institutional trading activity

BGI Genomics' controlling shareholder, BGI Tech Holdings, has proposed a share buyback program for the company. The proposed buyback would range from 250 million to 500 million yuan, to be funded by the company's own capital. This proposal comes amidst a broader market trend where institutional investors are actively trading stocks, with significant net buying and selling observed across various companies. AI

IMPACT This news pertains to corporate finance and stock market activity, with no direct impact on AI operations or development.

RANK_REASON The controlling shareholder of a publicly traded company proposed a significant share buyback. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    BGI Genomics: Controlling shareholder proposes company to repurchase shares worth 250 million - 500 million yuan

    36氪获悉,华大智造公告,控股股东深圳华大科技控股集团有限公司(简称“华大科技控股”)提议公司以自有资金和自筹资金通过上海证券交易所交易系统以集中竞价交易方式回购公司已发行的部分人民币普通股(A股)股票,本次回购资金总额不低于2.5亿元(含),不超过5亿元(含)。